HHS
HHS Calls Vertex's Case for Fertility Program a 'Distraction,' Urges Court to Rule in Its Favor
HHS is asking the court to affirm its Office of Inspector General's finding that paying for fertility services would run afoul of anti-kickback laws.
HHS Releases List of Medicare Part B Drugs Subject to Rebate Program
The program, aimed at reducing how much Americans spend on prescription drugs, includes several precision medicines.
HHS OIG Issues Unfavorable Opinion on Gene Therapy Developer's Fertility Preservation Program
Without more data on the risk of abuse associated with these programs, the agency won't provide immunity to drugmakers offering to pay for fertility services.
Vertex Pharmaceuticals Sues HHS, OIG Over Legality of Fertility Preservation Program
The firm is asking a court to determine that its program to pay for fertility treatments for patients on Casgevy doesn't violate anti-kickback and inducement laws.
Sickle Cell Gene Therapy Fertility Risks Spur Calls for Changes Allowing Industry Support Services
Gene therapy companies aren't covering fertility preservation for Medicaid patients due to anti-kickback laws, but CMS is exploring solutions in a model.